Lilly Antibody Drug Fails In A COVID-19 Study; Others Go On
Independent monitors had paused enrollment in the study two weeks ago because of a possible safety issue. But on Monday, the
It is a setback for one of the most promising treatment approaches for COVID-19. President
In a statement
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. The experimental drugs are concentrated versions of one or two specific antibodies that worked best against the coronavirus in lab and animal tests.
Kansas City Life Declares Quarterly Dividend
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News